Improving Bone Health Among RA Patients on Chronic Glucocorticoids
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 4,659
- 试验地点
- 2
- 主要终点
- Number of participants receiving Anti-osteoporosis Treatment
研究概览
简要总结
This quality improvement project is aimed at improving health care by identifying low cost strategies to get Rheumatoid Arthritis (RA) patients to more effectively communicate with their physicians about osteoporosis prevention and treatment (improving doctor-patient communication). The investigators will implement a direct to patient intervention to the population of interest (patients on chronic glucocorticoids) via story-telling, using an Internet based video. The target audience is people on chronic glucocorticoids not already receiving bones-specific osteoporosis medications to determine differences in post-intervention rates of osteoporosis care, and the rates of prescription anti-osteoporosis therapies.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Greater than or equal to 5 milligrams of prednisone or glucocorticoid dose equivalent for greater than or equal to 90 days within the previous 12 months
- •Medco member for entire study period
- •Refill steroid prescription online
排除标准
- •anti-osteoporosis medication in previous 12 months
结局指标
主要结局
Number of participants receiving Anti-osteoporosis Treatment
时间窗: within 3 - 12 months of exposure to video
Includes bisphosphonates, PTH, SERM, Calcitonin
次要结局
- Calcium and Vitamin D use(within 3 - 12 months of exposure to video)
- Patient-Physician Communication(within 3 - 12 months of exposure to video)
研究者
Kenneth Saag, MD, MSc
Jane Knight Lowe Professor of Medicine
University of Alabama at Birmingham